Hagerty secondary closes with 10.6375 million shares sold; company receives no proceeds

Hagerty, Inc. (NYSE: HGTY) closed an upsized selling-stockholder secondary offering on September 11, 2026, with Hagerty Holding Corp. selling 10.6375 million Class A shares at a public offering price of $11.95 each. Underwriters exercised their option in full. Hagerty received no offering proceeds.

For HGTY readers, the transaction is a sale by a selling stockholder, not a primary capital raise for the specialty insurance and driving-enthusiast company. The proceeds belong to Hagerty Holding Corp., which outlined a redemption benefiting the Kim Hagerty Revocable Trust.

The full option brought the sale to 10.6375 million shares

The offering comprised 9.25 million base shares and a 30-day option for underwriters to buy another 1.3875 million shares. That option was exercised in full, bringing the completed sale to 10.6375 million Class A shares. The September 9 pricing announcement had anticipated a close on or about September 11; the subsequent 8-K confirms the sale closed that day.

Hagerty Holding Corp. was the seller

Hagerty Holding Corp. was the selling stockholder. On September 9, it entered into the underwriting agreement alongside Hagerty, Inc. and The Hagerty Group, LLC, with Wells Fargo Securities and J.P. Morgan representing the underwriters.

Sale proceeds support an HHC redemption

Hagerty will receive none of the proceeds from the selling stockholder's share sale. HHC bears the underwriting discounts and commissions. In the pricing announcement, HHC said its net proceeds would fund a redemption of a corresponding number of HHC shares for the benefit of the Kim Hagerty Revocable Trust. The announcement did not provide a net proceeds dollar figure.

The 8-K confirms completion

The shares were offered under the effective Form S-3 registration statement numbered 333-261810. Hagerty reported the transaction in its September 11 Form 8-K, under Items 1.01, 8.01 and 9.01, accession number 0001193125-26-389275. Item 1.01 records the closing and full option exercise; the filing includes the underwriting agreement as Exhibit 1.1, DLA Piper LLP (US)'s opinion on the validity of the shares as Exhibit 5.1, with consent included as Exhibit 23.1, and the September 9 pricing announcement as Exhibit 99.1.